Taxus Pharmaceuticals, Inc. — Form D

Taxus Pharmaceuticals, Inc. of JINZHONG, F4, a company, filed a Form D exempt-offering notice with the SEC on 2012-05-10. The offering totals $4K, of which $4K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2012-05-10
• Form: D
• Accession: 0001549065-12-000001
• Industry: Pharmaceuticals
• Exemptions: 05
• Total offering: $4K
• Amount sold: $4K
• Minimum investment: $100
• Investors: 35
• Date of first sale: 2012-03-22
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-178016

Issuer

• Name: Taxus Pharmaceuticals, Inc.
• CIK: 0001549065
• Entity type: Corporation
• Jurisdiction: NEVADA
• Incorporated: 2012
• Address: ROOM 1202, 12TH FLOOR, JINZHONG, F4, 030600
• Phone: 863543366761

Officers, directors & promoters (8)

More

• CIK 1549065 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search